These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 97826)

  • 21. Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors.
    Knisely TL; Luckenbach MW; Fischer BJ; Niederkorn JY
    J Immunol; 1987 Jun; 138(12):4515-23. PubMed ID: 3108394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor cell destruction by cytotoxic T lymphocytes: the basis of reduced antitumor cell activity in syngeneic hosts.
    Fishelson Z; Berke G
    J Immunol; 1981 May; 126(5):2048-52. PubMed ID: 6783702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo suppression of the immune response to alloantigen by cholera enterotoxin.
    Henney CS; Lichtenstein LM; Gillespie E; Rolley RT
    J Clin Invest; 1973 Nov; 52(11):2853-7. PubMed ID: 4356000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-mediated immunity to Murine tumor allografts. Increase in the activities of activated thymus-derived cells following in vitro incubation.
    Gorczynski RM; Tigelaar RE
    Cell Immunol; 1975 Jul; 18(1):121-43. PubMed ID: 806353
    [No Abstract]   [Full Text] [Related]  

  • 26. Helper cells active in the generation of cytotoxicity to a syngeneic tumor.
    Hancock EJ; Kilburn DG; Levy JG
    J Immunol; 1981 Oct; 127(4):1394-7. PubMed ID: 6168688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor response elicited by a superantigen-transmembrane sequence fusion protein anchored onto tumor cells.
    Wahlsten JL; Mills CD; Ramakrishnan S
    J Immunol; 1998 Dec; 161(12):6761-7. PubMed ID: 9862706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Change of cell-mediated cytotoxicity with aging.
    Shigemoto S; Kishimoto S; Yamamura Y
    J Immunol; 1975 Jul; 115(1):307-9. PubMed ID: 807628
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of cyclosporine on in situ cellular and humoral immune responses during allograft rejection.
    Orosz CG; Sirinek LP; Zinn NE; Ferguson RM
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1175-7. PubMed ID: 3274303
    [No Abstract]   [Full Text] [Related]  

  • 30. Immune functions characteristic of SJL/J mice and their association with age and spontaneous reticulum cell sarcoma.
    Owens MH; Bonavida B
    Cancer Res; 1976 Mar; 36(3):1077-83. PubMed ID: 766961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of cell-mediated alloimmunity by BCG. II. Induction of specific, nonadherent, non-T-killer cells by BCG and alloantigen.
    Murahata RI; Mitchell MS
    J Natl Cancer Inst; 1982 Sep; 69(3):613-8. PubMed ID: 6810008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relation between the T cells responsible for cell-mediated cytotoxic killing of mastocytoma cells and the helper-cell effect.
    Igarashi T; Okada M; Kishimoto S; Yamamura Y
    Immunology; 1975 Jan; 28(1):37-47. PubMed ID: 803916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo activity of in vitro immunized lymphocytes. I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes.
    Rouse BT; Wagner H; Harris AW
    J Immunol; 1972 May; 108(5):1353-61. PubMed ID: 4623947
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of organophosphorus inhibitors, p-nitrophenol and cytochalasin B on cytotoxic killing of tumour cells by immune spleen cells, and the effect of shaking.
    Ferluga J; Asherson GL; Becker EL
    Immunology; 1972 Oct; 23(4):577-90. PubMed ID: 4628464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant cell arrest in thymus and spleen of mice bearing transplanted tumors.
    Haran-Ghera N; Krauthgamer R; Peled A
    J Immunol; 1981 Apr; 126(4):1241-4. PubMed ID: 6782158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo and in vitro antitumor activity expressed by cells of concomitantly immune mice.
    Tuttle RL; Knick VC; Stopford CR; Wolberg G
    Cancer Res; 1983 Jun; 43(6):2600-5. PubMed ID: 6133611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The decay of memory of cell-mediated cytotoxicity after primary sensitization in vivo against a tumor allograft.
    Jones KH; Adler WH
    Immunol Commun; 1978; 7(6):645-59. PubMed ID: 154468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central inhibition of cellular immunity to leukemia L1210 by isoantibody.
    Mitchell MS
    Cancer Res; 1972 Apr; 32(4):825-31. PubMed ID: 4622583
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice.
    Takei F; Levy JG; Kilburn DG
    J Immunol; 1976 Feb; 116(2):288-93. PubMed ID: 814160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Competitive inhibition of cytotoxic T lymphocyte-target cell conjugation. A direct evaluation of membrane antigens involved in cell-mediated immunity.
    Schick B; Berke G
    Transplantation; 1979 Jun; 27(6):365-8. PubMed ID: 111379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.